Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer
- PMID: 20224296
- PMCID: PMC2914492
- DOI: 10.4161/auto.6.3.11625
Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer
Abstract
Autophagy is an evolutionarily conserved lysosomal pathway for degrading cytoplasmic proteins, macromolecules, and organelles. While autophagy has become one of the most attractive topics in cancer research, the current autophagy literature is often viewed as confusing, because of its association with apparently contradictory roles, such as survival and cell death. Autophagy can serve as a tumor suppressor, as a partial reduction in autophagic capacity or defective autophagy (e.g., heterozygous knockdown BECN1 (+/-) in mice) provides an oncogenic stimulus, causing malignant transformation and spontaneous tumors. In addition, autophagy seems to function as a protective cell survival mechanism against environmental and cellular stress (e.g., nutrient deprivation, hypoxia and therapeutic stress) and causes resistance to antineoplastic therapies. Recent studies have demonstrated that the inhibition of autophagy in cancer cells may be therapeutically beneficial in some circumstances, as it can sensitize cancer cells to different therapies, including DNA-damaging agents, antihormone therapies (e.g., tamoxifen), and radiation therapy. This supports the hypothesis that inhibiting autophagy can negatively influence cancer cell survival and increase cell death when combined with anticancer agents, providing a therapeutic advantage against cancer. On the other hand, the induction of autophagy by the inhibition of anti-autophagic proteins, such as Bcl-2, PKCdelta, and tissue transglutaminase 2 (TG2), may lead to autophagic cell death in some apoptosis-resistant cancers (i.e., breast and pancreatic cancers), indicating that the induction of autophagy alone may also be used as a potential therapy. Overall, the data suggest that, depending on the cellular features, either the induction or the inhibition of autophagy can provide therapeutic benefits to patients and that the design and synthesis of the first-generation modulators of autophagy may provide the tools for proof of concept experiments and the impetus for translational studies that may ultimately lead to new therapeutic strategies in cancer.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2914492/bin/nihms222638f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2914492/bin/nihms222638f2.gif)
Similar articles
-
Autophagy: friend or foe in breast cancer development, progression, and treatment.Int J Breast Cancer. 2011;2011:595092. doi: 10.4061/2011/595092. Epub 2011 Sep 8. Int J Breast Cancer. 2011. PMID: 22295229 Free PMC article.
-
PKC delta and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cells.Autophagy. 2007 Sep-Oct;3(5):480-3. doi: 10.4161/auto.4349. Epub 2007 Apr 27. Autophagy. 2007. PMID: 17507797
-
Tissue transglutaminase inhibits autophagy in pancreatic cancer cells.Mol Cancer Res. 2007 Mar;5(3):241-9. doi: 10.1158/1541-7786.MCR-06-0229. Mol Cancer Res. 2007. PMID: 17374730
-
The role of autophagy in liver cancer: molecular mechanisms and potential therapeutic targets.Biochim Biophys Acta. 2013 Aug;1836(1):15-26. doi: 10.1016/j.bbcan.2013.02.003. Epub 2013 Feb 19. Biochim Biophys Acta. 2013. PMID: 23428608 Review.
-
Autophagy and cancer.Exp Mol Med. 2012 Feb 29;44(2):109-20. doi: 10.3858/emm.2012.44.2.033. Exp Mol Med. 2012. PMID: 22257886 Free PMC article. Review.
Cited by
-
The impact of nanomaterials on autophagy across health and disease conditions.Cell Mol Life Sci. 2024 Apr 17;81(1):184. doi: 10.1007/s00018-024-05199-y. Cell Mol Life Sci. 2024. PMID: 38630152 Free PMC article. Review.
-
Nanoplatform-Mediated Autophagy Regulation and Combined Anti-Tumor Therapy for Resistant Tumors.Int J Nanomedicine. 2024 Jan 26;19:917-944. doi: 10.2147/IJN.S445578. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38293604 Free PMC article. Review.
-
The Emerging Roles of the Metabolic Regulator G6PD in Human Cancers.Int J Mol Sci. 2023 Dec 7;24(24):17238. doi: 10.3390/ijms242417238. Int J Mol Sci. 2023. PMID: 38139067 Free PMC article. Review.
-
Targeting autophagy with SAR405 alleviates doxorubicin-induced cardiotoxicity.Cell Biol Toxicol. 2023 Dec;39(6):3255-3267. doi: 10.1007/s10565-023-09831-8. Epub 2023 Sep 28. Cell Biol Toxicol. 2023. PMID: 37768392
-
Unlocking the Molecular Secrets of Antifolate Drug Resistance: A Multi-Omics Investigation of the NCI-60 Cell Line Panel.Biomedicines. 2023 Sep 14;11(9):2532. doi: 10.3390/biomedicines11092532. Biomedicines. 2023. PMID: 37760973 Free PMC article.
References
-
- Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell. 2004;6:463–477. - PubMed
-
- Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005;5:726–734. - PubMed
-
- Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by beclin1. Nature. 1999;402:672–676. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous